Deborah Revaud

Title: Innovations by Deborah Revaud

Introduction

Deborah Revaud is a notable inventor based in Mondeville, France. She has made significant contributions to the field of immunology through her innovative work on lentiviral vectors. Her research focuses on generating immune responses against human T Lymphotrophic Virus Type 1.

Latest Patents

Deborah holds 1 patent for her invention titled "Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1." This invention relates to compositions, methods, and uses employing lentiviral vector particles for the induction of an immune response by administration to a human. The lentiviral vector particles comprise a lentiviral vector, wherein the DNA of the lentiviral vector includes a promoter directing the expression of a HTLV-1 p12p30-Tax-HBZ fusion protein. The invention encompasses these vectors, methods of making the vectors, and methods of using them, including medicinal uses.

Career Highlights

Deborah Revaud is associated with Theravectys, a company that focuses on developing innovative therapies. Her work at Theravectys has been instrumental in advancing research in the field of viral infections and immune responses.

Collaborations

Deborah collaborates with Cecile Bauche, who is also a prominent figure in the field. Their partnership enhances the research efforts at Theravectys and contributes to the development of effective therapeutic solutions.

Conclusion

Deborah Revaud's innovative work in the field of immunology, particularly her research on lentiviral vectors, showcases her commitment to advancing medical science. Her contributions are vital in the fight against viral infections, and her collaboration with other experts further strengthens her impact in the field.